Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806984 · ClinicalTrials.gov registry record
Improving Gap Closure Rates Using a Predictive Model
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 34,896
- Enrollment target
NCT04806984 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 34,896 participants.
The verdict
NCT04806984 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 34,896 participants
- Enrollment target
Study Summary
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
Interventions
- OTHER Participant outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34,896 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2022-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04806984
The ClinicalTrials.gov registry entry for NCT04806984 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34,896 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Participant outreach is the first listed.
NCT04806984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04806984 about?
NCT04806984 is a clinical study titled "Improving Gap Closure Rates Using a Predictive Model". NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
What is the current status of trial NCT04806984?
This trial is currently completed. The enrollment target is 34,896 participants. The study started on 2021-02-09. Estimated completion is 2022-02-27.
What interventions are being tested in trial NCT04806984?
The interventions under investigation include: Participant outreach (OTHER).
Who is sponsoring clinical trial NCT04806984?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.